These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 27457221

  • 1. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.
    Chow EK, Massie AB, Luo X, Wickliffe CE, Gentry SE, Cameron AM, Segev DL.
    Am J Transplant; 2017 Feb; 17(2):512-518. PubMed ID: 27457221
    [Abstract] [Full Text] [Related]

  • 2. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF, Osgood MJ.
    JAMA; 2004 Apr 21; 291(15):1871-4. PubMed ID: 15100206
    [Abstract] [Full Text] [Related]

  • 3. Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies.
    Kling CE, Biggins SW, Bambha KM, Feld LD, Perkins JH, Reyes JD, Perkins JD.
    JAMA Surg; 2023 Jun 01; 158(6):610-616. PubMed ID: 36988928
    [Abstract] [Full Text] [Related]

  • 4. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS.
    J Hepatol; 2017 Sep 01; 67(3):517-525. PubMed ID: 28483678
    [Abstract] [Full Text] [Related]

  • 5. MELD is MELD is MELD? Transplant center-level variation in waitlist mortality for candidates with the same biological MELD.
    Ishaque T, Kernodle AB, Motter JD, Jackson KR, Chiang TP, Getsin S, Boyarsky BJ, Garonzik-Wang J, Gentry SE, Segev DL, Massie AB.
    Am J Transplant; 2021 Oct 01; 21(10):3305-3311. PubMed ID: 33870635
    [Abstract] [Full Text] [Related]

  • 6. The effects of Share 35 on the cost of liver transplantation.
    Berumen J, Misel M, Vodkin I, Halldorson JB, Mekeel KL, Hemming A.
    Clin Transplant; 2017 May 01; 31(5):. PubMed ID: 28235131
    [Abstract] [Full Text] [Related]

  • 7. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS, Kaplan B, Jackson WE, Saben JL, Schold JD, Pomfret EA, Pomposelli JJ.
    Int J Surg; 2023 Sep 01; 109(9):2714-2720. PubMed ID: 37226874
    [Abstract] [Full Text] [Related]

  • 8. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J, Lee JG, Jung I, Joo DJ, Kim SI, Kim MS, Advisory Committee on Improving Liver Allocation.
    Sci Rep; 2019 May 16; 9(1):7495. PubMed ID: 31097768
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J, Kim DG, Lee JY, Lee JG, Joo DJ, Kim SI, Kim MS.
    Transplantation; 2019 Dec 16; 103(12):2515-2522. PubMed ID: 30985735
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy.
    Halazun KJ, Mathur AK, Rana AA, Massie AB, Mohan S, Patzer RE, Wedd JP, Samstein B, Subramanian RM, Campos BD, Knechtle SJ.
    Am J Transplant; 2016 Jan 16; 16(1):137-42. PubMed ID: 26561981
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Hsu EK, Shaffer ML, Gao L, Sonnenday C, Volk ML, Bucuvalas J, Lai JC.
    Gastroenterology; 2017 Oct 16; 153(4):988-995. PubMed ID: 28711630
    [Abstract] [Full Text] [Related]

  • 14. MELD as a metric for survival benefit of liver transplantation.
    Luo X, Leanza J, Massie AB, Garonzik-Wang JM, Haugen CE, Gentry SE, Ottmann SE, Segev DL.
    Am J Transplant; 2018 May 16; 18(5):1231-1237. PubMed ID: 29316310
    [Abstract] [Full Text] [Related]

  • 15. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S, Chau LC, Kitajima T, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Moonka D.
    Am J Transplant; 2020 Aug 16; 20(8):2184-2197. PubMed ID: 32155314
    [Abstract] [Full Text] [Related]

  • 16. Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients.
    Ross K, Patzer RE, Goldberg DS, Lynch RJ.
    Am J Transplant; 2017 Nov 16; 17(11):2879-2889. PubMed ID: 28695615
    [Abstract] [Full Text] [Related]

  • 17. HCC patients suffer less from geographic differences in organ availability.
    Schuetz C, Dong N, Smoot E, Elias N, Schoenfeld DA, Markmann JF, Yeh H.
    Am J Transplant; 2013 Nov 16; 13(11):2989-95. PubMed ID: 24011291
    [Abstract] [Full Text] [Related]

  • 18. Survival benefit of accepting livers from deceased donors over 70 years old.
    Haugen CE, Bowring MG, Holscher CM, Jackson KR, Garonzik-Wang J, Cameron AM, Philosophe B, McAdams-DeMarco M, Segev DL.
    Am J Transplant; 2019 Jul 16; 19(7):2020-2028. PubMed ID: 30614634
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.